Live Science on MSNOpinion
One molecule could usher revolutionary medicines for cancer, diabetes and genetic disease — but the US is turning its back on it
The U.S. government is divesting from mRNA vaccines, but will other uses of the technology be spared? In a time of ...
With $80 million in funding from a list of high-profile backers, the startup is developing bifunctional antibodies that drag ...
In a first for adults in Singapore, scientists are conducting gene editing trials on heart patients to correct defects at ...
Two days after Intellia voluntarily paused dosing due to safety concerns, the regulator stepped in with an official hold that ...
New to Growth Stocks? Here's 1 Every Investor Should Have on Their Radar. CRISPR Therapeutics has an approved gene-editing therapy, Casgevy, which can be a game changer for patients who need it. The ...
A researcher at the University of Houston finds management of diabetic ketoacidosis may center around reducing ketone levels ...
When six infants around the world were diagnosed with an odd trio of symptoms (diabetes, epilepsy, and abnormally small heads ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback